Explore Our Network
Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.
Showing 3 Patents
Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors
18-07-2023 • US-11702472-B2
ADUSUMILLI, PRASAD S. • SADELAIN, MICHEL • DIMITROV, DIMITER S. • FENG, YANG
Memorial Sloan Kettering Cancer Center • US Department of Health and Human Services
Mesothelin-targeted chimeric antigen receptors and uses thereof
28-04-2020 • US-10633441-B2
ADUSUMILLI, PRASAD S. • SADELAIN, MICHEL • DIMITROV, DIMITER S. • FENG, YANG
Memorial Sloan Kettering Cancer Center • US Department of Health and Human Services
Mesothelin-targeted chimeric antigen receptors and methods of making them
21-01-2020 • US-10538588-B2
ADUSUMILLI, PRASAD S. • SADELAIN, MICHEL • DIMITROV, DIMITER S. • FENG, YANG
Memorial Sloan Kettering Cancer Center • US Department of Health and Human Services